https://doi.org/10.55788/846b5f78
Dr Lindsey Ross described the implementation and 4 years of patient experience with outpatient subspecialty teleneurology visits at her academic institution [1]. “Virtual visits have the potential to improve patient access to neurological subspecialty care which otherwise often requires travel”, she said. Some of the advantages she mentioned were saving travel time, facilitation of long-distance follow-up, better compliance, continuous monitoring, and seeing the patient in his own environment.
In the study, virtual visits were conducted by personal smartphone or computer via videoconferencing with a provider. In 4 years, 3,958 patients completed 5,646 virtual visits. There was a broad applicability across subspecialties. Most visits concerned headache (21.4%), epilepsy (19.1%), spine (15.7%), and movement (10.8%). Virtual visits were utilised across a wide range of distances from the hospital: 29.8% were local (<50 miles), 25.9% near regional (50-150 miles), 21.6% far regional (151-270 miles), and 23.1% remote (>270 miles). On average, patients rated the virtual visit 4.7 and their provider 4.9 on a 5-point scale.
1. Ross L, et al. AAN 2019, plen01.004.
Posted on
Previous Article
« Eptinezumab reduces mean monthly migraine days Next Article
Immune tolerance by peptide-loaded tolerogenic dendritic cells »
« Eptinezumab reduces mean monthly migraine days Next Article
Immune tolerance by peptide-loaded tolerogenic dendritic cells »
Table of Contents: AAN 2019
Featured articles
Letter from the Editor
Interview with Prof. Natalia Rost
Alzheimer's Disease and other Dementias
Amyloid PET in cognitively impaired patients
Tight blood pressure control lowers risk of mild cognitive impairment
Epilepsy
Headache and Migraine
Multiple Sclerosis and NMOSD
Immune tolerance by peptide-loaded tolerogenic dendritic cells
Biotin, ocrelizumab, and ibudilast in progressive MS
No increased MS relapse risk postpartum
Neuromuscular Disorders
First-ever effective and safe treatment of CMT1A
Parkinson’s Disease and other Movement Disorders
Leukaemia and hypertension therapies tested in Parkinson’s disease
Stroke
Miscellaneous
Possibly lifesaving therapy in refractory PML
New AAN guideline for treating Tourette syndrome
Subspecialty teleneurology: feasible and highly valued
Related Articles
July 30, 2019
New AAN guideline for treating Tourette syndrome
July 30, 2019
Two experimental antibodies reduce amyloid levels
July 30, 2019
No increased MS relapse risk postpartum
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com